NPPB and hydrops fetalis: Specifically, all participants enrolled in HF-specific trials exhibited elevated brain natriuretic peptide or NT-proBNP levels, which are established HF diagnostic biomarkers, while diagnostic criteria in CVOTs were less strictly defined.